Your session is about to expire
← Back to Search
Participatory Systems Engagement for Addiction and Mental Health Care
Study Summary
This trial tests if a new method of engaging patients, providers, and policy makers in addiction and mental health care (participatory system dynamics) is more effective than status quo approaches.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Participatory System Dynamics (PSD)
- Group 2: Audit and Feedback (AF)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are any more participants being taken on board for this experiment?
"As sourced from clinicaltrials.gov, this medical research is no longer actively recruiting patients; the trial was initially posted on February 1st 2019 and last updated on August 3rd 2021. Despite that, there are still 2597 other trials open to participants at present."
What is the primary objective of this therapeutic experiment?
"The paramount goal of this two-year study is to determine the effectiveness of evidence-based practices for treating alcohol use disorder, depression, opioid use disorder and PTSD. Secondary objectives will involve analysing demographic measures (e.g., ethnicity and gender) with a 4 item survey as well as assessing psychological safety in workplace settings based on 27 questions from the Learning Organization Survey (LOS-27). Additionally, systems thinking competency across four constructs – complexity, feedback behaviour and time – will be assessed through codebook assessments and session observations."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger